Regorafenib recommended for use within NHS Wales for GIST – July 2015
We are delighted to report that Regorafenib has been recommended for use within NHS Wales for GIST Please see the AWMSG Website. This means that within three months of Ministerial approval (issued July 2015), regorafenib will be routinely available in the NHS across Wales. A fantastic outcome for GIST patients in Wales!
Continue reading
#100,000voices e-petition delivered to No. 10 Downing Street – 23 June 2015
Sincere thanks to everyone who has supported us with the call to retain regorafenib on the Cancer Drugs fund for GIST patients. Yesterday was our appointment with No. 10 Downing Street to deliver our #100,000voices e-petition containing 103,841 signatures supporting retention of regorafenib for GIST patients in England. We were joined by MP’s representing constituents […]
Continue readingRegorafenib is now officially back on the cancer drugs fund for GIST patients in England – 2015
23rd May 2015 – We are absolutely delighted to report that Regorafenib is now officially back on the cancer drugs fund for GIST patients in England. This is fantastic news and we would like to thank everyone who contributed to this decision: our fantastic #100,000voices team including William Bassett and the team at TMW. our Clinicians […]
Continue reading
regorafenib (Stivarga®) is accepted for use within NHS Scotland – 2015
regorafenib has been approved in Scotland for treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST) who have progressed on or are intolerant to prior treatment with imatinib and sunitinib. This advice takes account of the benefits of a Patient Access Scheme (PAS) that improves the cost-effectiveness of regorafenib and is contingent […]
Continue reading
GIST Support UK’s #100000voices Campaign 2015
March 2015 Jayne Bressington, vice chair of GIST Support UK (https://www.gistcancer.org.uk/), talks to BBC Radio Humberside about the government’s plans to stop funding for the rare cancer drug Regorafenib. The petition to stop these cuts has gained 100,000+ signatures and we are now calling on everyone to write to their local parliamentary candidates ahead of […]
Continue reading
Press Release: UKTV announces GIST Support UK as its Charity of the Year 2015
UKTV staff to cycle from London to Versailles in new charitable challenge London, Tuesday 27 January 2015 Award-winning media company, UKTV, announced today that GIST Support UK has been voted by staff as the company’s Charity of the Year for 2015. GIST (GastroIntestinal Stromal Tumour) is a rare form of cancer that affects both adults […]
Continue reading
Fundraising News: 2014 Virgin Money London Marathon in aid of Gist Support UK
On 13th April Robert Beale is running the 2014 Virgin Money London Marathon in aid of Gist Support UK. To Donate and wish him all the best visit the following link. http://uk.virginmoneygiving.com/RobertBeale2
Continue readingScottish Sarcoma Network – 2013
Patients who are interested, are welcome to attend any of the Sarcoma education days, which you can see on the Scottish Sarcoma Network website. www.ssn.scot.nhs.uk/ Any patients that are interested in these days, or would be interested in extra support, find out about available services or need help with any concerns are encouraged to get […]
Continue reading
Pub Quiz in aid of Gist Support UK – 2013
The Pub Quiz on Oct 17 in Tooting was an absolutely fantastic evening and success. First and foremost, the biggest mention must go to Barbara’s sister Jan for putting together the event pretty much single-handedly by all accounts – even persuading her son to fly in from Moscow – that is serious fundraising for you! […]
Continue readingEORTC funded Symptom Based Questionnaire project – 2013
Thanks to a great response from our meeting, listserve, facebook, twitter & on our website the trial below is now closed. Dr Sodergren extends her thanks and will be in contact with us again in the future. Trial Request (CLOSED) At our meeting in October 2013, Dr Samantha Sodergren came to request our help to recruit GIST patients […]
Continue reading